Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of December 2019, with a specific reporting date of December 11, 2019. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively reports on specific share acquisition transactions.
| Transaction Date | Instrument | Transaction Type | Price per Share | Total Volume |
|---|---|---|---|---|
| 2019-12-10 | Ordinary Shares (ISIN: GB0009252882) | Acquisition (Share Reward Plan) | £17.3090 | 126 Shares (Aggregated) |
Note: The total volume of 126 shares is derived from the sum of individual transactions listed in the filing.
Material Changes
This filing does not report material changes to the company's financial position, operations, or strategy compared to prior periods. It is a routine regulatory disclosure of executive share acquisitions.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The transactions were executed on the London Stock Exchange (XLON) and involved the acquisition of partnership shares and matching shares.
Important Facts for Investors
- Insider Activity: Nine individuals, including the CEO (Ms. E. Walmsley) and various Senior Vice Presidents, acquired shares on December 10, 2019.
- Transaction Nature: All transactions were acquisitions under the Company's Share Reward Plan, consisting of partnership shares and matching shares.
- Valuation: All shares were acquired at a uniform price of £17.3090 per share.
- Volume: Individual transactions ranged from 14 to 16 shares per executive.
- Financial Data: This document does not provide any corporate financial performance data (e.g., revenue or earnings).